LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Overview

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) Operating Income

Track LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s operating income ($-450M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-181145517.00

As of Mar 31, 2024

Annual Operating Income (TTM)

$-446070517.00

Trailing 12 months ending Mar 31, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) (YSBPW) FAQ

As of the most recent data (March 2024), YSBPW shows a operating income of $-450M. Scroll down for historical charts and peer comparison views.

Tracking YSBPW's operating income over time shows whether LakeShore Biopharma Co Ltd. - Warrants (15/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $-450M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has LakeShore Biopharma Co Ltd. - Warrants (15/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-450M) with ownership activity and broader fundamentals.